Long-term Safety Study for GSK573719 in Japanese
Long-term Safety Study for GSK573719 in Japanese
NCT ID: NCT01702363 Phase: PHASE3 Status: COMPLETED Enrollment: 131 Completion: 2013-12
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
GSK573719
Summary
The objective of this study is to evaluate the safety and tolerability of GSK573719 Inhalation Powder 125 mcg once-daily over 52 weeks in Japanese subjects with COPD.
Primary Outcome
Number of Participants With Any Adverse Event (AE) or Any Serious Adverse Event (SAE) Throughout the Treatment Period